Print

Akonni Biosystems Awarded $280,000 National Institutes of Health (NIH) Grant to Develop Benchtop Nucleic Acid Isolation Instrument  
10/2/2012 9:46:58 AM

FREDERICK, Md.--(BUSINESS WIRE)--Akonni Biosystems, a life science tools/molecular diagnostics company, has been awarded a $280,784 grant by NIH to develop a fully automated sample preparation workstation for isolating nucleic acids from lysis-resistant targets. The system will initially be used for general research, and eventually in clinical settings. This award enables Akonni to develop a simple-to-use and fully automated benchtop nucleic acid isolation workstation, ideally suited for purifying nucleic acid from Gram-positive bacteria such as staphylococci (e.g., methicillin-resistant Staphylococcus aureus, or MRSA), streptococci, and mycobacteria (e.g., tuberculosis), or from complex clinical matrices including blood and nasopharyngeal specimens. In the future, this same system is expected to be applicable for a range of molds and spores.
//-->